Companies: 10,795·Total market cap: $144.5T
Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc.

ELOXOTCHealthcare● Active
$6.20
$-2.80(-31.11%)
Market Cap$46952426
P/E Ratio
52W High$10
52W Low$0.00011
Overview

Eloxx Pharmaceuticals, Inc.(ELOX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

elox · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年5月31日

分析师评级与共识

基于过去 3 个月内 11 位华尔街分析师

SellBuy

Buy

11 位分析师

共识

评级分布

Strong Buy
0
Buy
8
Hold
3
Sell
0
Strong Sell
0
合计: 11 · 买入占比: 72.7%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $6.20

Eloxx Pharmaceuticals, Inc.(ELOX)的分析师共识为 Buy,基于过去 3 个月内 11 位华尔街分析师的评级。ELOX 的 12 个月平均目标价为 $0.00,相对当前价 $6.20 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$6.200.00%

1-day model range: $5.94–$6.46. Peak: $6.46 (+0.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

0%100%0%
0Buy
14Neutral
0Sell
RSI (14)50.0Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · ELOX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.00NEUTRAL
MA 10$0.00NEUTRAL
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $ELOX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.00NEUTRAL
EMA 10$0.00NEUTRAL
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $ELOX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Oppenheimer2023-07-11
Maintains
OutperformOutperform
Oppenheimer2023-04-06
Maintains
OutperformOutperform
Piper Sandler2022-05-23
Maintains
OverweightOverweight
HC Wainwright & Co.2022-05-09
Maintains
NeutralNeutral
Oppenheimer2021-12-17
Maintains
OutperformOutperform
HC Wainwright & Co.2021-11-18
Maintains
NeutralNeutral
HC Wainwright & Co.2021-11-11
Maintains
NeutralNeutral
Mizuho2021-06-30
Maintains
BuyBuy
B. Riley Securities2021-05-27
Maintains
BuyBuy
Citigroup2020-06-11
Downgrade ↓
BuyNeutral

Wall Street analysts have recently issued updated ratings on Eloxx Pharmaceuticals, Inc. (ELOX) stock. Of the recent 19 rating actions, 0 were upgrades and 1 were downgrades. 11 analysts currently cover ELOX.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ELOX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$0M

EPS This Year

$-6.65

EPS Next Year

$-8.04

↑ 20.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ELOX EPS of $-6.65 for the current fiscal year, based on estimates from 1 analysts. The ELOX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ELOX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ELOX 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

ELOX 的短期预测(明日)为 $6.20(+0.00%)。

Eloxx Pharmaceuticals, Inc. 在 OTC 上市,代码 ELOX。ELOX 在 2027 年的整体展望偏积极,在覆盖分析师中约 73% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ELOX 预测 · 8 个问题

根据 11 位华尔街分析师,ELOX 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $6.20,隐含约 +0.0% 的上行空间。

ELOX 目标价ELOX 分析师目标价ELOX 12个月目标价目标价 ELOX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.